Species distribution, sequence types and antimicrobial resistance of Acinetobacter spp. from cystic fibrosis patients

G A Rocha1, D F Lima1, E R Rodrigues1

  • 1Departamento de Microbiologia,Imunologia e Parasitologia,Universidade do Estado do Rio de Janeiro,Rio de Janeiro, RJ,Brazil.

Epidemiology and Infection
|December 29, 2017
PubMed

Insights

Acinetobacter species were identified in cystic fibrosis (CF) patients, revealing significant diversity and multidrug resistance. This highlights challenges in treating CF lung infections with these opportunistic pathogens.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • Acinetobacter species are significant healthcare-associated pathogens.
  • These bacteria are increasingly linked to antibiotic resistance and global outbreaks.
  • Their presence in cystic fibrosis (CF) patients is uncommon.

Purpose of the Study:

  • To characterize Acinetobacter species found in Brazilian cystic fibrosis patients.
  • To investigate the antimicrobial resistance profiles and genetic diversity of these isolates.

Main Methods:

  • Isolation and identification of Acinetobacter species from patient sputum samples.
  • Partial rpoB gene sequencing for species identification.
  • Multidrug resistance (MDR) assessment using disk diffusion tests.
  • Multilocus sequence typing (MLST) for genotypic diversity analysis.

Main Results:

  • Fifty-three Acinetobacter strains were identified from 39 CF patients, representing diverse species including A. baumannii, A. pittii, and A. nosocomialis.
  • Sixteen strains (30%) exhibited multidrug resistance (MDR).
  • Eight MDR carbapenem-resistant A. baumannii strains carried the bla OXA-23-like gene.
  • Thirty-three distinct sequence types (STs) were identified, with eight novel STs and several STs found in multiple patients, indicating potential transmission.

Conclusions:

  • This study reveals substantial species diversity of Acinetobacter in CF lung infections.
  • The high prevalence of antimicrobial resistance, including carbapenem resistance, poses significant therapeutic challenges.
  • Further research is needed to understand the clinical implications and transmission dynamics of Acinetobacter in CF patients.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
896
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
549
Multi-species Conserved Sequences02:51

Multi-species Conserved Sequences

Next-generation sequencing technologies have created large genomic databases of a variety of animals and plants. Ever since the human genome project was completed, scientists studied the genome of primates, mammals, and other phylogenetically distant living beings. Such large-scale  studies have provided new insights into the evolutionary relationship between organisms.
Although the genome of each species varies greatly from each other, a few sequences are highly conserved. Such conserved...
4.9K
Data: Types and Distribution01:19

Data: Types and Distribution

In biostatistics, data are the observations collected for analysis. There are two main types: parametric and non-parametric. Parametric data, which include continuous (e.g., weight) and discrete numerical data (e.g., number of tablets), assume a particular distribution pattern, often the normal distribution. Non-parametric data do not adhere to a specific distribution and typically comprise nominal (e.g., gender) and ordinal categorical data (e.g., pain scale ratings).
Distributions in...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
What is a Species?01:17

What is a Species?

Overview
50.6K